Articles by Johannes G. Khinast - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Johannes G. Khinast

Peer Reviewed: Numerical Simulation of Tablet Coating

The authors investigate the tablet-coating process using a combination of different simulation techniques.
Sep 2, 2012
By: Gregor Toschkoff, Daniele Suzzi, Siegfried Adam, Johannes G. Khinast

The authors investigate the tablet-coating process using a combination of different simulation techniques.

Printable Medicines: A Microdosing Device For Producing Personalized Medicines

The authors describe a new method for the production of personalised medicines involving the direct printing of drug solutions or suspensions containing APIs and excipients onto edible paper carrier materials utilising ultra-precise microdrop printing technology. The approach allows ultra-precise dosing of the API according to the specific requirements of each individual patient and is suited for highly active low-dose drugs.
Jan 7, 2011
By: Johannes G. Khinast, Andreas Zimmer, Guenter Brenn, Wolfgang Bauer, Bernhard Eitzinger, Daniela Strohmeier, Nina Schroedl, Michael M. Gruber, Christine Voura

The authors describe a new method for the production of personalised medicines utilising ultra-precise microdrop printing technology.

Effect of Droplet-Wake Phenomena on Mixing-Sensitive Pharmaceutical Reactions

Nov 2, 2006
By: Jodi Raffensberger, Benjamin Glasser, Johannes G. Khinast

Understanding the impact of reactive mass transfer and local flow in multiphase systems is crucial for maximizing reaction selectivity and minimizing the formation of byproducts. The authors study the influence of mixing on fast liquid–liquid reactions. The iodination of L-tyrosine was used to demonstrate the relationship of droplet size and shape on reaction selectivity and to verify computational predictions. By understanding that droplet dynamics affect the yield and selectivity of fast reactions, the formation of byproducts can be minimized by optimizing operating parameters.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here